Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05232305
Other study ID # Pomegranatepeelintype2DM
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date June 1, 2022

Study information

Verified date February 2022
Source Toros University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the effects of the consumption of bread produced with the addition of pomegranate peels, which has a high antioxidant content, on blood glucose and lipid parameters, and some oxidant-antioxidant enzymes and lipid peroxidation in individuals with type 2 diabetes.


Description:

Between 01.02.2022 and 30.05.2022 with Specialist Dr. Emel SENOL's approval, by Specialist Dr. Akkız Zuhal ÖZTAŞ The study will be conducted with 30 volunteers who present to the City Hospital Internal Medicine Polyclinic in Mersin.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date June 1, 2022
Est. primary completion date April 1, 2022
Accepts healthy volunteers No
Gender All
Age group 19 Years to 64 Years
Eligibility Inclusion Criteria: - Being diagnosed with type 2 diabetes for at least 5 years, - Using only oral antidiabetic - With a Body Mass Index (BMI) value = 25.0 kg/m2, - Signing the Informed Voluntary Consent Form, - Being in an age range of 19-64 years. Exclusion Criteria: - Having kidney, liver, and inflammatory diseases, - Being on insulin therapy, - Using prescription drugs and/or fiber supplements, - Taking vitamin and mineral supplements, - Being pregnant/lactating, - Consuming excessive alcohol (>2 drinks/day), - Being in the menstrual period, - Receiving gluten enteropathy, - Having allergy against pomegranate. - In addition, individuals with Covid-19-related condition during the study process will be excluded from the study.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Pomegranate Peel
Standard bread and test breads (with added pomegranate peel) to be used in the study will be produced by Asst. Prof. Özlem ÖZPAK AKKUS in the Nutrition Principles Laboratory of Toros University. For standard bread, 900 ml of water, 42 fresh yeast, 12 g of salt and 12 g of sunflower oil will be added to 1000 g of sifted whole wheat flour and the prepared bread mixture will be divided into 40 equal parts. To make bread with pomegranate peel added, 1000 g of sifted whole wheat flour, 20 g of pomegranate peel powder, 914 ml of water, 42 g of fresh yeast, 12 g of salt and 12 g of sunflower oil will be added and the prepared bread mixture is divided into 40 equal parts with 500 mg of pomegranate peel powder in each piece).

Locations

Country Name City State
Turkey Özlem ÖZPAK AKKUS Mersin Yenisehir

Sponsors (1)

Lead Sponsor Collaborator
Toros University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Biochemical Blood Parameters Examination of between group differences regarding lipid profile First day at the beginning of the study
Primary Biochemical Blood Parameters Examination of between group differences regarding HbA1c First day at the beginning of the study
Primary Biochemical Blood Parameters Examination of between group differences regarding insulin First day at the beginning of the study
Primary Biochemical Blood Parameters Examination of between group differences regarding TAC First day at the beginning of the study
Primary Biochemical Blood Parameters Examination of between group differences regarding TBARS First day at the beginning of the study
Primary Anthropometric Measurements - Weight Examination of between group differences regarding weight in kilogram First day at the beginning of the study
Primary Anthropometric Measurements - Height Examination of between group differences regarding height in meter First day at the beginning of the study
Primary Anthropometric Measurements - Body Mass Index Examination of between group differences regarding body mass index (BMI = weight in kilogram / height in meter 2) First day at the beginning of the study
Primary Anthropometric Measurements - Waist Circumference Examination of between group differences regarding waist circumference in centimeters First day at the beginning of the study
Primary Anthropometric Measurements - Hip Circumference Examination of between group differences regarding hip circumference in centimeters First day at the beginning of the study
Secondary Biochemical Blood Parameters Comparison of between group differences regarding lipid profile Eight weeks after the start of the study
Secondary Biochemical Blood Parameters Comparison of between group differences regarding HbA1c Eight weeks after the start of the study
Secondary Biochemical Blood Parameters Comparison of between group differences regarding insulin Eight weeks after the start of the study
Secondary Biochemical Blood Parameters Comparison of between group differences regarding TAC Eight weeks after the start of the study
Secondary Biochemical Blood Parameters Comparison of between group differences regarding TBARS Eight weeks after the start of the study
Secondary Anthropometric Measurements - Weight Examination of between group differences regarding weight in kilogram Eight weeks after the start of the study
Secondary Anthropometric Measurements - Height Examination of between group differences regarding height in meter Eight weeks after the start of the study
Secondary Anthropometric Measurements - Body Mass Index Examination of between group differences regarding body mass index (BMI = weight in kilogram / height in meter 2) Eight weeks after the start of the study
Secondary Anthropometric Measurements - Waist Circumference Examination of between group differences regarding waist circumference in centimeters Eight weeks after the start of the study
Secondary Anthropometric Measurements - Hip Circumference Examination of between group differences regarding hip circumference in centimeters Eight weeks after the start of the study
See also
  Status Clinical Trial Phase
Completed NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum N/A
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Active, not recruiting NCT05566847 - Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Completed NCT04965506 - A Study of IBI362 in Chinese Patients With Type 2 Diabetes Phase 2
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Active, not recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Active, not recruiting NCT06010004 - A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Phase 3
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A